Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Individualized assessment and meticulous planning are crucial for successful brow and upper eyelid surgery.

Hair and nail cells share similar proteins, indicating a common differentiation pathway.

The adapalene-benzoyl peroxide gel works better and faster for acne treatment than using either ingredient alone, with manageable side effects.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Researchers found specific genes in the part of hair follicles that could help treat hair disorders.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

The hair follicle's connective tissue is a key source of a certain collagen in human scalp skin.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Maintain a natural, masculine look while rejuvenating the eye area with careful, tailored techniques.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Modulating BMP activity changes the number, size, shape, and type of ectodermal organs.

Using a special stem cell formula on the scalp once a month for six months helped people with hair loss grow more hair.

SIPHL1 from tomato enhances plants' response to low phosphate levels.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Nuclear shape and chromatin changes affect gene expression in skin cell differentiation.